BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 8152805)

  • 1. Products of the TAL2 oncogene in leukemic T cells: bHLH phosphoproteins with DNA-binding activity.
    Xia Y; Hwang LY; Cobb MH; Baer R
    Oncogene; 1994 May; 9(5):1437-46. PubMed ID: 8152805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TAL1, TAL2 and LYL1: a family of basic helix-loop-helix proteins implicated in T cell acute leukaemia.
    Baer R
    Semin Cancer Biol; 1993 Dec; 4(6):341-7. PubMed ID: 8142619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TAL2, a helix-loop-helix gene activated by the (7;9)(q34;q32) translocation in human T-cell leukemia.
    Xia Y; Brown L; Yang CY; Tsan JT; Siciliano MJ; Espinosa R; Le Beau MM; Baer RJ
    Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11416-20. PubMed ID: 1763056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct t(7;9)(q34;q32) breakpoints in healthy individuals and individuals with T-ALL.
    Marculescu R; Vanura K; Le T; Simon P; Jäger U; Nadel B
    Nat Genet; 2003 Mar; 33(3):342-4. PubMed ID: 12567187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Products of the TAL1 oncogene: basic helix-loop-helix proteins phosphorylated at serine residues.
    Cheng JT; Hsu HL; Hwang LY; Baer R
    Oncogene; 1993 Mar; 8(3):677-83. PubMed ID: 8437851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The MAP kinase phosphorylation site of TAL1 occurs within a transcriptional activation domain.
    Wadman IA; Hsu HL; Cobb MH; Baer R
    Oncogene; 1994 Dec; 9(12):3713-6. PubMed ID: 7970731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of a novel GTP binding protein, DRG, with TAL oncogenic proteins.
    Mahajan MA; Park ST; Sun XH
    Oncogene; 1996 Jun; 12(11):2343-50. PubMed ID: 8649774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assembly of the oncogenic DNA-binding complex LMO2-Ldb1-TAL1-E12.
    Ryan DP; Duncan JL; Lee C; Kuchel PW; Matthews JM
    Proteins; 2008 Mar; 70(4):1461-74. PubMed ID: 17910069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The TAL1/Scl basic helix-loop-helix protein blocks myogenic differentiation and E-box dependent transactivation.
    Hofmann TJ; Cole MD
    Oncogene; 1996 Aug; 13(3):617-24. PubMed ID: 8760303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formation of in vivo complexes between the TAL1 and E2A polypeptides of leukemic T cells.
    Hsu HL; Wadman I; Baer R
    Proc Natl Acad Sci U S A; 1994 Apr; 91(8):3181-5. PubMed ID: 8159721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preferred sequences for DNA recognition by the TAL1 helix-loop-helix proteins.
    Hsu HL; Huang L; Tsan JT; Funk W; Wright WE; Hu JS; Kingston RE; Baer R
    Mol Cell Biol; 1994 Feb; 14(2):1256-65. PubMed ID: 8289805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific in vivo association between the bHLH and LIM proteins implicated in human T cell leukemia.
    Wadman I; Li J; Bash RO; Forster A; Osada H; Rabbitts TH; Baer R
    EMBO J; 1994 Oct; 13(20):4831-9. PubMed ID: 7957052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two site-specific deletions and t(1;14) translocation restricted to human T-cell acute leukemias disrupt the 5' part of the tal-1 gene.
    Bernard O; Lecointe N; Jonveaux P; Souyri M; Mauchauffé M; Berger R; Larsen CJ; Mathieu-Mahul D
    Oncogene; 1991 Aug; 6(8):1477-88. PubMed ID: 1886719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fusion of the NH2-terminal domain of the basic helix-loop-helix protein TCF12 to TEC in extraskeletal myxoid chondrosarcoma with translocation t(9;15)(q22;q21).
    Sjögren H; Wedell B; Meis-Kindblom JM; Kindblom LG; Stenman G
    Cancer Res; 2000 Dec; 60(24):6832-5. PubMed ID: 11156374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive and negative transcriptional control by the TAL1 helix-loop-helix protein.
    Hsu HL; Wadman I; Tsan JT; Baer R
    Proc Natl Acad Sci U S A; 1994 Jun; 91(13):5947-51. PubMed ID: 8016094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The highest affinity DNA element bound by Pbx complexes in t(1;19) leukemic cells fails to mediate cooperative DNA-binding or cooperative transactivation by E2a-Pbx1 and class I Hox proteins - evidence for selective targetting of E2a-Pbx1 to a subset of Pbx-recognition elements.
    Knoepfler PS; Kamps MP
    Oncogene; 1997 May; 14(21):2521-31. PubMed ID: 9191052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of casein kinase II phosphorylation sites in Max: effects on DNA-binding kinetics of Max homo- and Myc/Max heterodimers.
    Bousset K; Henriksson M; Lüscher-Firzlaff JM; Litchfield DW; Lüscher B
    Oncogene; 1993 Dec; 8(12):3211-20. PubMed ID: 8247525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The T cell oncogene Tal2 is necessary for normal development of the mouse brain.
    Bucher K; Sofroniew MV; Pannell R; Impey H; Smith AJ; Torres EM; Dunnett SB; Jin Y; Baer R; Rabbitts TH
    Dev Biol; 2000 Nov; 227(2):533-44. PubMed ID: 11071772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helix-loop-helix proteins LYL1 and E2a form heterodimeric complexes with distinctive DNA-binding properties in hematolymphoid cells.
    Miyamoto A; Cui X; Naumovski L; Cleary ML
    Mol Cell Biol; 1996 May; 16(5):2394-401. PubMed ID: 8628307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple mechanisms induce ectopic expression of LYL1 in subsets of T-ALL cell lines.
    Nagel S; Venturini L; Meyer C; Kaufmann M; Scherr M; Drexler HG; MacLeod RA
    Leuk Res; 2010 Apr; 34(4):521-8. PubMed ID: 19608273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.